Recombinant coagulation factor VIIa: from the concept to clinical application in hemophilia treatment in 2000.
about
Bypassing agent prophylaxis in people with hemophilia A or B with inhibitorsRecombinant factor VIIa concentrate versus plasma-derived concentrates for treating acute bleeding episodes in people with haemophilia and inhibitorsRecombinant Factor VIIa concentrate versus plasma derived concentrates for the treatment of acute bleeding episodes in people with haemophilia and inhibitorsRecombinant Factor VIIa concentrate versus plasma derived concentrates for the treatment of acute bleeding episodes in people with Haemophilia A and inhibitorsThe use of recombinant activated coagulation factor VII for spine surgeryGuidelines for assessing appropriateness of pediatric transfusion.The potential use of recombinant activated factor VII in trauma and surgery.Recombinant factor VIIa in paediatric bleeding disorders--a 2006 review.Recombinant activated factor VII for haemophilia patients with inhibitors undergoing orthopaedic surgery: a review of the literature.Optimal use of recombinant factor VIIa in the control of bleeding episodes in hemophilic patients.Bypassing agent prophylaxis in people with hemophilia A or B with inhibitors.Activation of platelets in whole blood by recombinant factor VIIa by a thrombin-dependent mechanism.Successful induction of immune tolerance in a patient with haemophilia B with inhibitor.Recombinant factor VIIa prophylaxis in a patient with severe congenital factor VII deficiency.Hemostatic effect of recombinant factor VIIa, NN1731 and recombinant factor VIII on needle-induced joint bleeding in hemophilia A mice.Thrombin-activable factor X re-establishes an intrinsic amplification in tenase-deficient plasmas.Recombinant factor VIIa reduces transfusion requirements in liver transplant patients with high MELD scores.Use of recombinant factor VIIa in infants with severe coagulopathy.Recombinant coagulation factor VIIa labelled with the fac-99 mTc(CO)3-core: synthesis and in vitro evaluation of a putative new radiopharmaceutical for imaging in acute bleeding lesion
P2860
Q24187021-40070A48-69EA-45D6-B283-6741D993F69DQ24187069-38757672-0453-4146-AC15-BF174C735530Q24236388-5B1F01C6-C28B-4CE1-BDAA-FF98219EE8BEQ24247217-8DF6F5D8-0A69-4286-970D-441E290E5DB5Q33360946-38017288-5305-40E6-B8E8-356F955F66D8Q34991606-9D6750E7-FFB9-42EC-8F56-AA071EDC3C6CQ35760073-21974EC2-E311-4C7A-A61C-B070A739F3F1Q36570888-EF1664A4-BCD8-44A6-B9EC-6AA9170A8EE1Q37032862-F64718EE-F413-4A43-BD5D-408130788E5FQ37778292-E9DAC04B-DF33-4B93-8494-CDED73CA5D3BQ42692841-8B2C9DF9-C7E3-4C04-ABA1-37747D8A855BQ44537661-0F67555D-17DC-4BF8-A7E9-C27DF7CE123FQ45861602-658C0C23-8756-4E10-B1E9-5190935FDD04Q45874642-B87BE086-4C4C-4ADB-8050-4958477E6328Q45876175-5C487C90-CBFC-4DCC-8146-01F34E5CDD33Q45887421-106EDDBA-E0C4-4C0D-BCA1-7156DC1D915EQ46473807-7AB144EC-0B35-4E06-8BA7-B046A0BED7E4Q47677743-772A9AF5-761F-49A2-8257-C03E3FD51EE5Q57681765-342700F5-4001-4460-810E-7D9633E3736E
P2860
Recombinant coagulation factor VIIa: from the concept to clinical application in hemophilia treatment in 2000.
description
2000 nî lūn-bûn
@nan
2000 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Recombinant coagulation factor ...... hemophilia treatment in 2000.
@ast
Recombinant coagulation factor ...... hemophilia treatment in 2000.
@en
Recombinant coagulation factor ...... hemophilia treatment in 2000.
@nl
type
label
Recombinant coagulation factor ...... hemophilia treatment in 2000.
@ast
Recombinant coagulation factor ...... hemophilia treatment in 2000.
@en
Recombinant coagulation factor ...... hemophilia treatment in 2000.
@nl
prefLabel
Recombinant coagulation factor ...... hemophilia treatment in 2000.
@ast
Recombinant coagulation factor ...... hemophilia treatment in 2000.
@en
Recombinant coagulation factor ...... hemophilia treatment in 2000.
@nl
P356
P1476
Recombinant coagulation factor ...... hemophilia treatment in 2000.
@en
P2093
P304
P356
10.1055/S-2000-8453
P577
2000-01-01T00:00:00Z